ALEAF - Aleafia Health Announces the Passing of Director Daniel Milliard

TORONTO, June 17, 2021 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), with great regret announces the passing of Daniel Milliard, a valued member of its Board of Directors.

“We are tremendously sad that our dear friend and colleague Daniel Milliard has passed away. It was a privilege to serve with Dan on Aleafia’s board and previously at Emblem, where I witnessed firsthand his integrity, work ethic, and business acumen,” said Aleafia Health Director Loreto Grimaldi. “Through decades of experience as a senior executive and director, Dan provided wise counsel and a steady hand that will be greatly missed. On behalf of our board of directors and management, I would like to extend our deepest condolences to Dan’s wife Maria and family.”

For Investor & Media Relations:

Nicholas Bergamini, VP Investor Relations
1-833-879-2533
IR@AleafiaHealth.com
LEARN MORE: www.AleafiaHealth.com

About Aleafia Health :

Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company offering cannabis health and wellness services and products in Canada and with sales and operations in Australia and Germany. The Company operates medical clinics, education centres and production facilities for the production and sale of cannabis.

Aleafia Health owns four significant licensed cannabis production facilities, including the first large-scale, legal outdoor cultivation facility in Canadian history. The Company produces a diverse portfolio of commercially proven, high-margin derivative products including oils, capsules, edibles, sublingual strips, and vapes. Aleafia Health operates the largest national network of medical cannabis clinics and education centres staffed by MDs, nurse practitioners and educators and operates internationally in three continents.